Introduction
The pathophysiology of schizophrenia is incompletely understood, but two of the most robust abnormalities are elevated striatal dopamine activity 1,2 and prefrontal cortical dysfunction. 3, 4 In particular, five independent molecular imaging studies have found pre-synaptic dopamine overactivity in patients with schizophrenia and first episode of psychosis (reviewed in Laruelle and Howes et al. 1, 2 ) . Functional imaging studies of tasks that engage executive functions, such as verbal fluency, show differential engagement of the prefrontal cortex in patients with schizophrenia relative to controls, [5] [6] [7] even after controlling for impaired task performance.
The first episode of schizophrenia is preceded by a prodromal phase characterized by symptoms and signs that comprise an 'At-Risk Mental State' (ARMS), such as attenuated psychotic symptoms and a deterioration in global functioning. 8 Individuals with these symptoms can be identified using standardized, structured psychopathological assessments 8 and have an increased risk of developing a psychotic disorder within 24 months. 9 Studying subjects in the prodromal phase provides a means of prospectively investigating the pathophysiological processes that underlie the vulnerability and the development of schizophrenia. 10 Neuropsychological studies indicate that the ARMS is associated with cognitive impairments that are qualitatively similar to, but less severe than those seen in schizophrenia, with consistent evidence of deficits on tasks that engage executive functions. 11, 12 The impairment in verbal fluency performance is particularly marked, with performance about one s.d. below the normative level. 13 The neurofunctional alterations that putatively underpin these behavioural impairments implicate the prefrontal cortex and have recently been investigated using functional Magnetic Resonance Imaging (fMRI) (reviewed in Fusar-Poli et al.
). A recent [
18 ]-Fluoro-L-DOPA Positron Emission Tomography (F-DOPA PET) study found that striatal dopamine function was also elevated in the ARMS, 15 as it is in schizophrenia. 1, 2 The increase was localized to the associative subregion of the striatum, which is anatomically and functionally linked to prefrontal cortex. [16] [17] [18] Moreover, it was correlated with the degree to which performance in the ARMS subjects was impaired on a verbal fluency task, 15 a paradigm that is critically dependent on prefrontal function. These observations suggest that elevated striatal dopaminergic activity in the ARMS may be related to executive dysfunction, perhaps mediated through altered prefrontal function.
The aim of this study was to examine the relationship between dopamine function and prefrontal activation in people experiencing prodromal symptoms of psychosis. Using two different neuroimaging protocols in the same patients is logistically difficult, and the only previous investigation that has addressed this issue 19 was performed in a small sample of patients with chronic schizophrenia (n = 6). Altered prefrontal activation during the Wisconsin Card Sort test (measured using 15 O 2 -PET) was correlated with increased subcortical dopamine function, assessed using F-DOPA PET. However, whether this relationship is evident at the onset of psychosis or is related to effects of chronic illness or treatment with antipsychotic medication (which can alter both dopaminergic 20 and prefrontal function 21 ) is unclear. We sought to address these issues by using PET and functional MRI to study medication-naive subjects who were experiencing prodromal symptoms of psychosis. F-DOPA PET was used to assess striatal dopamine function and functional MRI data were collected during a verbal fluency task. Based on recent data from previous studies, 14, 15, 22 we predicted that the ARMS would be associated with elevated dopamine function in the striatum and with altered activation in the prefrontal cortex during verbal fluency. We then tested the hypothesis that the severity of the dopaminergic and prefrontal abnormalities would be inter-correlated.
Materials and methods

Subjects
ARMS Group (n = 20): Individuals meeting PACE criteria for the an At-Risk Mental State (ARMS) were recruited from Outreach and Support in South London. 23 The diagnosis was based on assessment by two experienced clinicians using the Comprehensive Assessment for the ARMS (CAARMS), 8 and a consensus meeting with the clinical team. All subjects were antipsychotic naive at the time of the fMRI scanning. Two subjects were receiving an antidepressant treatment. The subjects were representative of the local population of people presenting with an ARMS in terms of age, gender, ethnicity and duration and intensity of symptoms.
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Controls: Healthy volunteers (n = 14) were recruited via advertisements in the local media. Subjects were excluded if there was a history of neurological disorder or they met DSM-IV criteria for a substance dependence or abuse disorder.
All subjects in both groups were right-handed, as evaluated using the Lateral Preferences Inventory, 24 and native speakers of English.
Clinical measures
The severity of symptoms in the clinical groups was assessed at the time of scanning using the Comprehensive Assessment of At-Risk Mental States (CAARMS 8 ) and the Positive and Negative Symptom Scale. 25 The first three items on the CAARMS, which cover symptoms of attenuated delusions, hallucinations and thought disorder, were summed to give a score for attenuated 'positive' psychotic symptoms. Consumption of illicit substances, tobacco and coffee/ tea was evaluated using a modified version of the Cannabis Experience Questionnaire (CEQ). 26 Premorbid intelligence was assessed using the National Adult Reading Test (NART). 27 fMRI scanning Image acquisition. Images were acquired on a 1.5 Tesla Signa (GE) system at the Maudsley Hospital, London. T2*-weighted images were acquired with a TR of 2 s, 38 Â 3 mm slices, with a 0.3 mm gap in 14 axial planes. A gradient-echo sequence (TR 4000 ms, TE 40 ms) was used with the acquisition of each volume compressed into the first 1250 ms of the repetition time, creating a 2750 ms window in which subjects could articulate a response in the absence of scanner noise. 6 To facilitate anatomical localization of activation, a high resolution inversion recovery image dataset was also acquired, with 3 mm contiguous slices and an in-plane resolution of 3 mm (TR 1600 ms, TI 180 ms, TE 80 ms).
Verbal fluency task: Subjects were required to overtly articulate a word beginning with a visually presented letter. The stimuli, each subtending an angle of 51, were presented on a black screen, viewed through a mirror. Cognitive load was modulated with two levels of task difficulty: 'easy' and 'hard' conditions using letters that differed with respect to the ease with which volunteers can usually generate words in response to them. The 'easy' condition involved the letters L, T, C, P, S; the 'hard' condition O, N, E, F, G. 6 Incorrect responses were defined as words that were proper names, repetitions or grammatical variations of the previous word and 'pass' responses. Letters were presented in 28 s (s) blocks of seven stimuli at 4 s intervals. The control condition of word repetition comprised 28 s blocks of seven presentations of the word 'rest' at 4 s intervals, in which subjects were required to read aloud. Five blocks of each condition (Hard/Easy/Repetition) were presented in random order. Verbal responses were recorded via an MRI-compatible microphone using Cool Edit 2000 software (Syntrillium Software Corporation; http://www.syntrillium.com). To ensure that subjects heard their responses clearly, their speech was transmitted by an MRI-compatible microphone, amplified by a computer sound card and relayed back through an acoustic MRI sound system (Ward Ray, Hampton Court, UK) and noise insulated, stereo headphones at a volume of 91 ± 2 dB. The effect of the group on response accuracy during scanning was tested using an ANOVA.
Analysis of fMRI data. Functional MRI data were analysed using Statistical Parametric Mapping (SPM5; Wellcome Department of Cognitive Neurology, London, United Kingdom) running in MATLAB7.1. All volumes were realigned to the first volume, corrected for motion artifacts, mean adjusted by proportional scaling, normalized into standard stereotactic space (template provided by the Montreal Neurological Institute) and smoothed using a 6-mm full width at half-maximum Gaussian kernel. The time series were high pass filtered to eliminate lowfrequency components (filter width 128 s) and adjusted for systematic differences across trials. In the first level analysis the onset times (in seconds) for each trial was convolved with a canonical haemodynamic response function. Each task condition (easy, hard) was then contrasted against the baseline condition (repeating the word 'rest') for each subject. To test the hypothesis that there were between-group differences, we performed a second-level analysis comparing the activation during verbal fluency, independent of task demand (easy and hard word generation combined versus word repetition) between the two groups (controls and ARMS), using an ANOVA between-subjects test. As we were testing an a-priori hypothesis regarding group effects in the frontal lobe, 14, 28 we used a frontal lobe mask generated by WFU Pickatlas (http://www.fmri.wfubmc.edu/) 29 for second-level group contrasts. The mask includes frontal areas corresponding to Brodmann areas (BA) 4, 6, 8, 9, 46, 10, 11, 47, 45, 44, 32 and 24. All results are reported at a voxelwise level corrected for multiple comparisons (FWE P < 0.05).
PET scanning
Image acquisition. Images were acquired using a 3-D PET scanner (ECAT/EXACT3D; Siemens/CTI, Knoxville, TN, USA), which has a spatial resolution of 4.8±0.2 mm and a sensitivity of 69 cps/Bq/ml. 30 High resolution images of the whole brain were reconstructed from 95 planes with a slice spacing of 2.425 mm. All subjects received 150 mg carbidopa and 400 mg entacapone orally 1 h before scanning to reduce the formation of radiolabelled metabolites, 31, 32 which may potentially cross the blood-brain barrier. 33 Subjects were positioned with the orbitomeatal line parallel to the transaxial plane of the tomograph. Head position was marked and monitored via laser crosshairs and a camera. A 5-min transmission scan was carried out before radiotracer injection using a 150-MBq cesium-137 rotating point source to correct for attenuation and scatter. Approximately 150 MBq of F-DOPA was administered by intravenous injection immediately following a 30-s background frame. The emission scan lasted 95 min with 26 time frames (comprising a 30-s background frame, four 60 s, three 120 s, three 180 s and finally 15 300 s frames). Subjects underwent structural MR imaging to exclude intracranial abnormalities. The PET data from eight of the ARMS and five of the control subjects have been previously reported as part of a separate study. 15 Image analysis. Movement correction was conducted by de-noising the non-attenuated dynamic image 34 and realigning the frames to a single frame acquired 6 min post injection using a mutual information algorithm. 35 The transformation parameters were then applied to the corresponding attenuationcorrected frames, and the realigned frames combined to create a movement-corrected dynamic image for the regions of interest (ROI) analysis. 36 The ROI analysis was carried out blind to group status by one investigator. Standardized regions in Montreal Neurologic Institute space were defined in the cerebellum using a probabilistic atlas 37 and in the whole striatum delineated using the criteria described by Mawlawi et al. 38 In addition, the F-DOPA template used in a previous study 39 (constructed from images acquired using the ECAT/EAXCT3D scanner) was normalized together with the ROI atlas to each individual PET summation image using statistical parametric mapping (SPM2; Wellcome Department of Cognitive Neurology, London, England). The striatal subdivisions were delineated according to the criteria used by Martinez et al. 40 to yield limbic, associative and sensorimotor subregions. 40 These subdivisions reflect the topographical arrangement of corticostriatal projections, with projections to the limbic subregions from areas such as the hippocampus and amygdala, projections to the associative subregions from associative areas such as the dorsolateral prefrontal cortex, and projections to the sensorimotor subregions from motor cortex, premotor and supplementary motor cortex. Graphical analysis was used to calculate influx constants (Ki values) for the whole striatal ROI and the functional subdivisions relative to uptake in the reference region for left and right sides combined. 41 The cerebellum was used as the reference region as this has been shown to have the lowest F-Dopa uptake in the brain. 42 An analysis of variance was used to determine whether there was an effect of the group on Ki value.
Integration of fMRI and PET data
We extracted the cluster average b-values for each region that showed significant between-group effects during the verbal fluency task using MarsBar in SPM5, and correlated these with the Ki values across both groups (separate correlations were conducted for different striatal subregions and corrected for multiple comparisons using the Bonferroni test). The significance of these correlations was assessed using Spearman's correlation coefficient as the BOLD data did not show a normal distribution. Cook's distance test was used to assess the effect of potential outliers on the correlations. Fisher's r to z transformation was used to compare correlations' coefficients. Only a minority of the ARMS and control subjects used illicit substances, and this was mainly occasional use of cannabis. The mean number of cannabis joints used per week was of 0.01 and 0.02 in the control and ARMS group respectively, and there was no significant difference between the groups in cannabis use (cannabis cigarettes smoked per week t = À1.284, d.f. = 32, P = 0.208). As expected, there was a significant group difference in the severity of psychopathology, both when rated using the CAARMS (total scores: t = À4.500, d.f. = 32, P < 0.001; disorders of thought content: t = À7.377, d.f. = 32, P < 0.001; perceptual disorders: t = À4.175, d.f. = 32, P < 0.001; speech disorders: t = À5.907, d.f. = 32, P < 0.001) and the Positive and Negative Symptom Scale (total scores: t = À3.248, d.f. = 32, P = 0.003; positive scores, t = À4.933, d.f. = 32, P < 0.001; negative scores t = À3.182, d.f. = 32, P = 0.003, general scores, t = À3.744, d.f. = 32, P < 0.001). The rate of transition to psychosis in the sample was not yet available at the time of writing, as the subjects are still undergoing clinical follow up.
Results
Clinical
F-Dopa uptake
Across the striatum subdivisions a significant group effect was observed for the associative striatum (F = 4.244, d.f. = 1, P = 0.048) but not for the limbic striatum (F = 3.650, d.f. = 1, P > 0.05) or the sensorimotor striatum (F = 0.660, d.f. = 1, P > 0.05, Figure 1 ). The associative Ki was significantly elevated by 6.33% (Cohen's d effect size, associative striatum = 0.75) in the ARMS compared with the control group. There was no significant interaction between laterality and group for the striatal subdivisions or the whole striatum (P > 0.05).
Verbal fluency task
Task performance. There was no significant difference in the accuracy of responses during the verbal fluency task between the ARMS (mean correct 84.41%) and control groups (mean correct 85.10%) (t-test P = 0.139, P = 0.890).
Regional activation. Main effect of task: Across all subjects word generation relative to word repetition was associated with activation in several regions in the left frontal lobe. The largest cluster of activation was in the inferior frontal gyrus and adjacent insula, with additional engagement of the superior and medial frontal gyri and the left anterior cingulate gyrus. There was also subcortical activation in the putamen bilaterally and in the body of the right caudate (Table 1) .
Group differences in activation: The ARMS group showed significantly greater activation than the healthy subjects in the left inferior frontal gyrus and right middle frontal gyrus (Table 1 and Figure 2a) . Post hoc analysis confirmed that in these areas, there was task-related activation in both groups and that this activation was greater in the ARMS than in the control group. Conversely, no brain areas showed greater activation in the control group than the ARMS group.
Relationship between dopamine function and prefrontal activation
Region of interest analysis. Within the ARMS sample, there was a positive correlation between BOLD response in the left inferior frontal region (where there was significantly greater activation in the ARMS than Control group) and the Ki value in the associative part of the striatum (r = 0.681, P = 0.001, R 2 = 0.464) (Figure 2b ). This correlation remained significant after the removal of potential outliers identified using Cook's Distance test. There was no significant correlation in the control group (r = À0.261, P = 0.368, R 2 = 0.068). This between-groups difference in correlation of BOLD response with striatal Ki itself was significant (Fisher's r to z transformation P = 0.005). In the other frontal region where activation differed between the two groups (the right middle frontal gyrus) there was no significant correlation with the Ki value in the associative striatum in either group.
Relationship between dopamine function and task performance. There were no significant correlations between response accuracy during verbal fluency and Ki in the striatal subdivisions or in the striatum as a whole (all P > 0.05). 
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Discussion
The key finding from this study is that in individuals at very high risk of schizophrenia, altered prefrontal activation during a task of executive function was directly related to striatal hyperdopaminergia. This provides in vivo evidence of a link between dopamine dysfunction and the perturbed prefrontal function, which may underlie the deficits in executive processing evident in people with prodromal symptoms of psychosis. It extends a previous finding of a similar relationship in patients with established schizophrenia 19 by showing that it predates the onset of frank psychosis and is not attributable to effects of chronic illness or treatment with antipsychotic medication.
When performing the verbal fluency task, both controls and ARMS subjects activated left prefrontal cortex, including left inferior frontal gyrus, in line with previous studies in controls 28 and patients with schizophrenia. 43 As predicted, activation within this network was significantly different in the two groups, with the ARMS subjects showing greater activation in the left inferior frontal gyrus and in the right middle frontal gyrus. As the differential activation we observed was evident in the context of comparable response accuracy, and the analysis was restricted to images associated with correct responses, it is unlikely to be related to group differences in task performance and may instead reflect a difference at the neurophysiological level. 44 Greater engagement of prefrontal regions in the ARMS group suggests that more activation may have been required to achieve the same behavioural output as controls, and can be interpreted as a manifestation of less efficient prefrontal processing, as has been described in patients with schizophrenia. 45 In line with such a hypothesis a separate longitudinal fMRI study by our group has showed that the normalization of the exaggerated inferior frontal response during verbal fluency is associated with 12 months psychopathological improvement of prodromal symptoms. 46 Functional abnormalities in the prefrontal cortex are consistent with evidence that these areas are sites of reduced grey matter volume in the ARMS, 47, 48 in first episode psychosis 49 and in established schizophrenia. 50 Longitudinal structural imaging studies have indicated that the transition to psychosis from the ARMS is associated with a reduction in grey matter volume in the prefrontal cortex. [51] [52] [53] Our finding of an elevated Ki for F-Dopa in the associative striatum of the ARMS group is consistent with our previous result in a larger sample, 15 as well as with evidence that striatal F-Dopa uptake and dopamine release are elevated in patients with first episode and chronic schizophrenia. 1, 54, 55 Its localization to the associative striatum is of particular interest, as this subregion is strongly connected to the prefrontal cortical areas that are normally critical for the performance of verbal fluency and other executive tasks. 56 As all of the ARMS subjects were naive to antipsychotic medication, neither the fMRI nor the PET findings are attributable to an effect of the drug treatment. 20 The verbal fluency task used in the scanner was paced, which facilitated image acquisition and minimized performance differences between subjects, which can confound the interpretation of differential activation in functional imaging studies. 44 This was reflected in the high response accuracy, which was near ceiling in both groups and probably accounted for the absence of the relationship between task performance and striatal dopamine function that we Abnormal prefrontal activation P Fusar-Poli et al previously observed 15 when we used an unpaced verbal fluency paradigm as is typically employed in neuropsychological studies.
In line with our main hypothesis, alterations in prefrontal activation and striatal dopamine function in the ARMS group were directly correlated. This correlation was specific to the left inferior frontal gyrus, a brain area classically linked to language production and the most robust site of activation when healthy subjects perform verbal fluency paradigms. 28 The correlation was specific to the subjects at high risk of psychosis, suggesting that the observed relationship was related to pathophysiological changes associated with the ARMS. A correlation between striatal F-Dopa uptake and abnormal prefrontal blood flow during the Wisconsin Card Sort test has previously been described in patients with schizophrenia, 19 although in that study elevated dopamine function was associated with reduced, as opposed to increased prefrontal activation. This difference is likely to reflect methodological differences between the two studies 57 the previous study examined patients with schizophrenia who had previously been treated with antipsychotics, used PET rather than fMRI to measure prefrontal activation and employed a different cognitive task on which the patients' performance was significantly impaired. Whether prefrontal activation in patients with schizophrenia is reduced or increased relative to controls depends on the task employed and whether there are group differences in behavioural performance. 43 Studies of verbal fluency in which performance in patients was impaired have often reported reduced prefrontal activation in schizophrenia, whereas some of those in which performance was matched have shown either no difference or greater activation relative to controls. 58 A further difference between the two studies is that the correlation we observed was with activation in the inferior frontal cortex, whereas that the previous study was in a more dorsal part of the prefrontal cortex. These findings are consistent with the hypothesis that the core functional abnormalities underlying neurocognitive impairments in schizophrenia consist of reduced activation of the dorsolateral prefrontal cortex and a compensatory activation of the ventral prefrontal cortex. 45 Both alterations may thus be related to aberrant striatal dopaminergic function, directly in the case of dorsolateral prefrontal cortex and indirectly as a consequence of changes in the dorsolateral prefrontal cortex in the case of the ventral prefrontal cortex.
The prefrontal cortex projects directly to the striatum and to the cell bodies of the midbrain dopamine neurons that project to the striatum. 59, 60 Prefrontal cortical lesions in experimental animals result in elevated striatal dopaminergic function, and prefrontal activity is correlated with midbrain dopamine function in human volunteers. 19 Activity in dopaminergic terminals within the striatum may thus be controlled by prefrontal cortex, and it has been proposed that these serve as a 'brake' on the striatal dopamine system. 61 However, there are also indirect projections to prefrontal cortex from the striatum via the thalamus. 59 Animal studies indicate that experimentally elevated striatal dopaminergic function leads to impaired behavioural flexibility (an index of executive dysfunction) and working memory, and reduced dopamine turnover and D1 receptor levels in prefrontal cortex. 62 This suggests that striatal hyperdopaminergia can influence prefrontal activity and impair neurocognitive function. As greater elevation in striatal dopamine function has been previously found to be associated with greater symptom severity, 15 striatal hyperdopaminergia may underlie both symptoms and neurocognitive function, although it is also possible that another pathway underlies all these relationships. The extent to which the correlation we observed reflects an effect of prefrontal cortex on striatal dopamine function or vice versa cannot be determined from this study, but may be clarified by longitudinal neuroimaging studies of individuals with prodromal signs of schizophrenia. The participants in this study have not yet been followed up for a sufficient period to determine their long-term clinical outcome, and the extent to which the findings relate to the subsequent onset of psychosis remains to be determined. Recent data from a large longitudinal study indicates that about 35% of subjects at clinical risk for psychosis will develop the disorder over 24 months or so. 63 In conclusion, we found that increased striatal dopaminergic function is associated with abnormal prefrontal activation in people at high risk for schizophrenia, indicating that two of the fundamental neurochemical and neurocognitive pathophysiological features of the disorder may not only predate the onset of illness, but are inter-related. Abnormal dopamine and prefrontal function are not simply preclinical features of schizophrenia, but they are also evident in subjects who are at high risk but will never develop the disorder. 64 This indicates that these abnormalities, until now regarded as key pathophysiological features of schizophrenia, are correlates of vulnerability to the disorder, as opposed to the clinical disorder per se. This has important implications for the aetiology of schizophrenia, as it suggests that these abnormalities alone are insufficient, and that the development of illness requires their interaction with additional factors, such as perturbed GABA and glutamate function 65 or with neural abnormalities in other brain regions, such as the medial temporal cortex. 52 
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